Notably, STV reduced the number of cells surviving doxorubicin treatment not only in 17-DMAG-resistant but also in parental 4T1 cells, suggesting that NTRI reduces the subpopulation of tumor cells that drive tumor recurrence following chemotherapy and thereby extends relapse-free survival. Here, NTM is linked to neoplasm.